From 2013.igem.org

Revision as of 08:10, 26 September 2013

iGEM Home

• Home
• Team
  • Our Journey
  • Attributions
• Project
  • CRISPR
  • Flavours
  • Parts
  • Modeling
• Notebook
  • CRISPR
  • Caffeine
  • Flavours
  • Protocols
  • Safety
• Human Practices
  • Interviews
  • Survey Results
  • Marketing Strategy
  • Space-R
  • GMO Labeling
  • GMO Timeline
• Achievements

CRISPR

CRISPRs (Clustered Regularly Interspaced Short Palindromic Repeats) are loci found in some bacterial and archaeal genomes that, together with associated cas (CRISPR-associated) genes function as an adaptive immune system in prokaryotes. While the details of spacer sequence acquisition are still being worked out, it is known that exogenous DNA is processed by Cas proteins into short (~30 base) sequences that are incorporated into the host genome between repeat sequences to form the spacer elements. The repeat-spacer-repeat array is constitutively expressed (pre-CRISPR RNAs, pre-crRNAs) and processed by Cas proteins to form small RNAs (crRNAs). These small RNAs are loaded into Cas proteins and guide them to initiate the sequence-specific cleavage of the target sequence (or the protospacer).

As an adaptive immune response, we wanted to know if CRISPR could be put together in a modular way to confer resistance to known phage genomes - vaccinating the host. We first wrote programs capable of identifying the most broadly neutralizing spacer region from compiled phage genomes. We then assembled the minimum components into BioBricks and conducted the necessary proof-of-concept experiments in E. coli. First, we characterized the dynamics of phage infection in our specific host strain and experimental protocols. We then built a system that protects E.coli against T4 phage infection and are beginning to understand some guidelines and assemble design rules for assembling CRISPR components to provide immunity. Currently, we are carrying out experiments with T7 phage, performing some in vitro characterizations, and exploring new possibilities with our working and manipulable CRISPR system.

Ultimately, we hope that large-scale fermenters could be vaccinated against collapse caused by environmental phage infection. To extend the application of this approach, we designed specific neutralization elements that allow for population level programming of a culture. Check out our population control section where we envision this being first applied to yogurt where, for example, the biosynthesis of flavour combinations is controlled by targeted phage addition.

Spacer Selection

Design

Results

Normal growth under T4 Phage Infection

Combinatorial CRISPR-Cas9 element assembly

Arabinose dependent growth under T4 infection

Growth kinetics of immunized culture